Endocrinology
Cohort Study | Modifiable risk factors may reduce the risk of type 2 diabetes in patients with a history of gestational diabetes.
23 Sep, 2022 | 13:08h | UTCNews Release: Healthy lifestyle linked to 90% lower risk of diabetes in susceptible women – BMJ Newsroom
Commentary on Twitter
Women with a history of diabetes in pregnancy can still reduce their chances of developing type 2 diabetes by adopting a healthy lifestyle, such as eating healthy, stopping smoking, exercising regularly, and not being overweight, finds new studyhttps://t.co/UkArl7ZyBS
— The BMJ (@bmj_latest) September 22, 2022
RCT | Insulin Glargine vs. Glimepiride vs. Sitagliptin vs. Liraglutide resulted in similar microvascular outcomes and death rates in patients with Type 2 diabetes not controlled with metformin.
22 Sep, 2022 | 13:20h | UTCGlycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes – New England Journal of Medicine (link to abstract – $ for full-text)
Related Study: Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes – New England Journal of Medicine
News Release: Two popular diabetes drugs outperformed others in large clinical trial – National Institutes of Health
Study shows that the leading causes of hospitalization of adults with diabetes are changing.
22 Sep, 2022 | 13:08h | UTCCommentaries:
The changing character of diabetes complications – The Lancet Diabetes & Endocrinology (free registration required)
Reasons for hospital admissions in people with type 2 diabetes are changing – MedicalXpress
Review | Adrenal insufficiency in cirrhosis.
22 Sep, 2022 | 12:59h | UTCAdrenal Insufficiency in Cirrhosis – Journal of the Endocrine Society
RCT | Effects of an exercise program on brain health outcomes for children with overweight or obesity.
21 Sep, 2022 | 13:17h | UTCNews Release: Study finds schoolchildren who exercise perform better academically – University of Granada
Commentary: Exercise Improves Brain Health in Overweight, Obese Youth – HealthDay
Commentary on Twitter
Intelligence, cognitive flexibility and academic performance improved following a 20-week RCT based on aerobic + resistance training among children with overweight or obesity. @ortegaporcel @profithugr @canalUGR and collaborators. #OpenAccess #Research https://t.co/XYddOoO7e7 pic.twitter.com/rZpjJxe3tr
— JAMA Network Open (@JAMANetworkOpen) August 30, 2022
Network M-A | Associations between statins and adverse events in secondary prevention of cardiovascular disease.
20 Sep, 2022 | 13:30h | UTC
RCT | Open-source automated insulin delivery in Type 1 Diabetes.
19 Sep, 2022 | 12:41h | UTCOpen-Source Automated Insulin Delivery in Type 1 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
Video summary: Open-Source Automated Insulin Delivery in Type 1 Diabetes – NEJM
Commentaries:
Automated Insulin Delivery Ups Time in Target Glucose Range in T1D – HealthDay
Cohort Study | Patients diagnosed with diabetes by oral glucose tolerance test without elevated HbA1c had similar cardiovascular and renal disease risks as those without diabetes.
15 Sep, 2022 | 13:12h | UTC
Commentary on Twitter
#OriginalResearch: Oral glucose tolerance test diagnosed #diabetes were not confirmed by HbA1c during 4 year follow-up. Cases without HbA1c confirmation had similar vascular risk as the diabetes-free population. @whitehall2study @MikaKivimaki #AHAJournals https://t.co/ujC8cjRS7S pic.twitter.com/CRR3zlm5x2
— Circulation (@CircAHA) August 30, 2022
Consensus recommendations for the use of Automated Insulin Delivery (AID) technologies in clinical practice.
15 Sep, 2022 | 13:06h | UTC
Cohort Study | A 7-year study of the durability of improvements in pain, physical function, and work productivity after Roux-en-Y gastric bypass and sleeve gastrectomy.
15 Sep, 2022 | 13:03h | UTCNews Release: Beyond weight loss: Improvements in pain, mobility persist long after bariatric surgery – University of Pittsburgh
Author Interview: Long-term Changes in Pain, Physical Function, and Work Productivity After Bariatric Surgery – JAMA
USPSTF Statement | The current evidence is insufficient to recommend routine screening for prediabetes and type 2 diabetes in children and adolescents.
14 Sep, 2022 | 13:23h | UTCEditorials:
Recommendations for Screening Children and Adolescents for Prediabetes and Type 2 Diabetes – JAMA
Broader Screening for Youth-Onset Type 2 Diabetes—We Just Are Not There Yet – JAMA Network Open
Patient Page: Screening for Type 2 Diabetes in Children and Adolescents – JAMA
Author Interview: USPSTF Recommendation: Screening for Prediabetes and Diabetes in Children and Adolescents – JAMA
Expert Opinion | Clinical management of pregnancy in women with polycystic ovary syndrome.
14 Sep, 2022 | 13:02h | UTC
Cluster RCT | Tighter vs. less tight glycemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity.
13 Sep, 2022 | 13:21h | UTC
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study.
13 Sep, 2022 | 13:02h | UTCRelated study: Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing’s syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
RCT | In youths with new-onset type 1 diabetes, intensive glucose control for 24 months with a closed-loop system did not help to preserve pancreatic function.
11 Sep, 2022 | 22:57h | UTCClosed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
Preservation of C-Peptide Secretion Examined in Youth With T1D – HealthDay
Commentary on Twitter (video summary)
In patients with newly diagnosed type 1 diabetes, it is uncertain whether intensive glucose control can prevent the decline in endogenous insulin secretion. New research findings are summarized in a short video. https://t.co/gJeYus4G5z pic.twitter.com/igclSnyanu
— NEJM (@NEJM) September 10, 2022
Cohort study showed a possible link between artificial sweeteners and heart disease.
11 Sep, 2022 | 22:55h | UTCNews Release: Possible link between artificial sweeteners and heart disease – BMJ Newsroom
Original Study: Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Santé cohort – The BMJ
A randomized crossover trial with 12 patients showed that a bihormonal “artificial pancreas” with closed-loop glucose control increases patients’ time on euglycemia after total pancreatectomy.
11 Sep, 2022 | 22:45h | UTCBihormonal Artificial Pancreas With Closed-Loop Glucose Control vs Current Diabetes Care After Total Pancreatectomy: A Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Commentary: Novel Bihormonal Artificial Pancreas Beneficial After Pancreatectomy – HealthDay
Network M-A | Comparative efficacy of lipid‐lowering therapies added to maximally tolerated statins for the reduction of LDL cholesterol.
11 Sep, 2022 | 22:38h | UTC
Systematic Review | Surgery for the treatment of obesity in children and adolescents.
11 Sep, 2022 | 22:29h | UTCSurgery for the treatment of obesity in children and adolescents – Cochrane Library
Summary: Surgery for the treatment of obesity in children and adolescents – Cochrane Library
Study shows bariatric surgery is more effective than lifestyle for type 2 diabetes remission.
8 Sep, 2022 | 14:27h | UTCNews Release: Bariatric surgery more effective than lifestyle for type 2 diabetes remission – Pennington Biomedical Research Center
Original Study: Diabetes Remission in the Alliance of Randomized Trials of Medicine Versus Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D) – Diabetes Care
M-A | Hypocalcemia following thyroidectomy among patients who have previously undergone bariatric surgery.
8 Sep, 2022 | 14:25h | UTCHypocalcaemia following thyroidectomy among patients who have previously undergone bariatric surgery: systematic review and meta-analysis – British Journal of Surgery (link to abstract – $ for full-text)
RCT | Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes.
7 Sep, 2022 | 12:30h | UTCAdvanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study – The Lancet Endocrinology (link to abstract – $ for full-text)
Commentary: ‘Artificial Pancreas’ Best in Poorly Controlled Type 1 Diabetes – Medscape (free registration required)
Commentary on Twitter
New—Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 #diabetes (ADAPT): a randomised controlled study https://t.co/XrrmoDuQLy #T1D pic.twitter.com/GSLWA3xX7F
— The Lancet Diabetes & Endocrinology (@TheLancetEndo) September 2, 2022
RCT | Weekly Somapacitan is noninferior to daily GH in children with GH deficiency.
6 Sep, 2022 | 14:25h | UTC
The Australian obesity management algorithm: a simple tool to guide the management of obesity in primary care.
5 Sep, 2022 | 14:31h | UTC
Nonalcoholic fatty liver disease: review of management for primary care providers.
5 Sep, 2022 | 14:18h | UTC